Related Experiment Video
Updated: Mar 18, 2026
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Chronic Infection and Severe Asthma
1Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ 85724, USA.
Abstract:
Chronic bacterial infection is implicated in both the development and severity of asthma. The atypical bacteria Mycoplasma pneumoniae and Chlamydophila pneumoniae have been identified in the airways of asthmatics and correlated with clinical features such as adult onset, exacerbation risks, steroid sensitivity, and symptom control. Asthmatic patients with evidence of bacterial infection may benefit from antibiotic treatment directed towards these atypical organisms. Examination of the airway microbiome may identify microbial communities that confer risk for or protection from severe asthma.
Insights
Chronic bacterial infections, particularly atypical bacteria like Mycoplasma pneumoniae and Chlamydophila pneumoniae, are linked to severe asthma. Antibiotic treatment targeting these bacteria may benefit asthmatic patients.
Area of Science:
- Pulmonology
- Microbiology
- Immunology
Background:
- Chronic bacterial infections are associated with asthma development and severity.
- Atypical bacteria, Mycoplasma pneumoniae and Chlamydophila pneumoniae, are found in asthmatic airways.
- These infections correlate with asthma features like adult onset and exacerbation risk.
Purpose of the Study:
- To investigate the role of atypical bacterial infections in asthma.
- To explore the potential benefits of antibiotic treatment for asthmatics with bacterial infections.
- To examine the airway microbiome for risk or protective microbial communities in severe asthma.
Main Methods:
- Identification of Mycoplasma pneumoniae and Chlamydophila pneumoniae in asthmatic airways.
- Correlation analysis between bacterial presence and clinical asthma features (onset, exacerbations, steroid sensitivity, symptom control).
- Assessment of airway microbiome composition.
Main Results:
- Atypical bacteria were identified in asthmatic patients.
- Bacterial presence correlated with specific clinical asthma characteristics.
- Potential for antibiotic therapy targeting atypical organisms was suggested.
Conclusions:
- Chronic atypical bacterial infections are relevant to asthma pathogenesis and severity.
- Antibiotic therapy against Mycoplasma pneumoniae and Chlamydophila pneumoniae may be a viable treatment strategy.
- Airway microbiome analysis offers insights into asthma risk and protection.
More Related Videos
Related Concept Videos
01:29Asthma-I: Introduction
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...